The ACA is a start to a value-driven health care approach because it has changed a huge part of the health care systems regulations regarding payments to hospitals and physicians to promote health care value, patient out come, and delivery of services. For example, bundled payment methods, incentives, voluntary hospital, benchmark methods, and physician public reporting encouragement. But there is still a long way to an entirely value-driven health care system because of the complexity of collaborating different stakeholders to support a value driven system. On one side of the U.S. health care system, you have Governmental administered competition consisting of National Health Service-Monopsony (Buyer dominate). On the other, you have value-based administered competition composed of a free market, provider/insurer oligopoly, and provider monopoly (seller dominant). Balancing the health care marketplace and perfecting the right amount of care and cost associated with a diagnosis is profoundly complex (policy, 2014). There is still a lot of experimentation and pressure among different stakeholders to reduce cost at the same time as increasing the deliverance of
The ACA is a start to a value-driven health care approach because it has changed a huge part of the health care systems regulations regarding payments to hospitals and physicians to promote health care value, patient out come, and delivery of services. For example, bundled payment methods, incentives, voluntary hospital, benchmark methods, and physician public reporting encouragement. But there is still a long way to an entirely value-driven health care system because of the complexity of collaborating different stakeholders to support a value driven system. On one side of the U.S. health care system, you have Governmental administered competition consisting of National Health Service-Monopsony (Buyer dominate). On the other, you have value-based administered competition composed of a free market, provider/insurer oligopoly, and provider monopoly (seller dominant). Balancing the health care marketplace and perfecting the right amount of care and cost associated with a diagnosis is profoundly complex (policy, 2014). There is still a lot of experimentation and pressure among different stakeholders to reduce cost at the same time as increasing the deliverance of